Display options
Share it on

NPJ Vaccines. 2018 Jan 09;3:1. doi: 10.1038/s41541-017-0041-5. eCollection 2018.

Bi-valent polysaccharides of Vi capsular and O9 O-antigen in attenuated .

NPJ vaccines

Pei Li, Qing Liu, Hongyan Luo, Kang Liang, Yue Han, Kenneth L Roland, Roy Curtiss, Qingke Kong

Affiliations

  1. 1Institute of Preventive Veterinary Medicine, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan 611130 China.
  2. 2Center for Infectious Diseases and Vaccinology, The Biodesign Institute, Arizona State University, Tempe, AZ 85287 USA.
  3. 3College of Animal Science and Technology, Southwest University, Chongqing, 400715 China.
  4. 4Department of Infectious Diseases and Immunology, University of Florida, Gainesville, FL 32608 USA.

PMID: 29354293 PMCID: PMC5760606 DOI: 10.1038/s41541-017-0041-5

[No abstract available.]

Conflict of interest statement

RC is a founder and Chief Scientific Officer of Curtiss Healthcare, Inc., which is developing vaccines for food animals. The remaining authors declare no competing financial interests.

References

  1. Vet Microbiol. 2016 Apr 15;186:189-98 - PubMed
  2. Infect Immun. 2010 Jan;78(1):527-35 - PubMed
  3. Vaccine. 2006 Jan 12;24(2):116-23 - PubMed
  4. Mol Microbiol. 2009 Oct;74(1):175-93 - PubMed
  5. Infect Immun. 2007 Mar;75(3):1382-92 - PubMed
  6. Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S20-3 - PubMed
  7. PLoS One. 2016 Jan 07;11(1):e0145945 - PubMed
  8. Pediatr Infect Dis J. 2010 Nov;29(11):1035-9 - PubMed
  9. Int J Med Microbiol. 2009 Apr;299(4):233-46 - PubMed
  10. Infect Immun. 2002 Jul;70(7):3457-67 - PubMed
  11. Infect Immun. 1994 Sep;62(9):3984-93 - PubMed
  12. Proc Natl Acad Sci U S A. 2016 Jun 14;113(24):6719-24 - PubMed
  13. Cell Microbiol. 2008 Apr;10(4):876-90 - PubMed
  14. Mol Microbiol. 1998 Aug;29(3):835-50 - PubMed
  15. Infect Immun. 2011 Feb;79(2):830-7 - PubMed
  16. Vaccine. 2017 May 15;35(21):2862-2869 - PubMed
  17. Science. 1997 Sep 26;277(5334):2007-11 - PubMed
  18. Carbohydr Res. 2003 Nov 14;338(23):2503-19 - PubMed
  19. EcoSal Plus. 2016 Nov;7(1): - PubMed
  20. Vaccine. 2012 Aug 3;30(36):5389-95 - PubMed
  21. Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1906-11 - PubMed
  22. Bull World Health Organ. 2004 May;82(5):346-53 - PubMed
  23. Lancet. 2005 Aug 27-Sep 2;366(9487):749-62 - PubMed
  24. Infect Immun. 2000 Apr;68(4):2135-41 - PubMed
  25. Infect Immun. 1987 Dec;55(12):3035-43 - PubMed
  26. Cell Mol Life Sci. 2004 Nov;61(22):2812-26 - PubMed
  27. Vaccine. 2007 Feb 9;25(8):1416-25 - PubMed
  28. Infect Immun. 2011 Jun;79(6):2481-8 - PubMed
  29. MBio. 2013 Jul 16;4(4):null - PubMed
  30. J Infect Dis. 2004 Aug 1;190(3):565-70 - PubMed
  31. J Infect Dis. 1996 Jun;173(6):1408-14 - PubMed
  32. Int J Mol Sci. 2016 Mar 22;17 (3):416 - PubMed
  33. PLoS One. 2012;7(9):e45609 - PubMed
  34. Curr Opin Infect Dis. 2001 Oct;14(5):573-8 - PubMed
  35. Vaccine. 2013 Oct 1;31(42):4874-80 - PubMed
  36. Clin Vaccine Immunol. 2014 May;21(5):712-21 - PubMed
  37. PLoS One. 2013 Jul 18;8(7):e69306 - PubMed
  38. Microbes Infect. 2001 Nov-Dec;3(14-15):1271-9 - PubMed
  39. Cell Microbiol. 2008 Jan;10(1):247-61 - PubMed
  40. Mol Microbiol. 2003 Mar;47(5):1395-406 - PubMed
  41. Vaccine. 2004 Sep 3;22(25-26):3243-55 - PubMed
  42. J Immunol. 1979 Sep;123(3):1376-81 - PubMed
  43. Mol Microbiol. 1991 Jun;5(6):1447-57 - PubMed
  44. J Infect Dev Ctries. 2011 May 28;5(5):324-37 - PubMed
  45. PLoS Pathog. 2010 Aug 19;6(8):e1001060 - PubMed
  46. Infect Immun. 1997 Feb;65(2):452-6 - PubMed
  47. Infect Immun. 2002 Apr;70(4):1739-49 - PubMed
  48. J Bacteriol. 1983 Apr;154(1):269-77 - PubMed
  49. PLoS Pathog. 2014 Jul 03;10(7):e1004207 - PubMed

Publication Types

Grant support